Formulation Comprising Bioactive Agents And Method Of Using Same

Publication: US2012004170A1
Published: 2012-01-05
Family Size: 16
Granted: Yes (4/16)

Simple SummaryContent extracted from patent full text and abstract with AI.

This patent describes formulations and methods for creating bioactive microparticles containing bone morphogenetic protein-2 (BMP-2). These microparticles are designed to improve the stability, storage, and delivery of BMP-2 for use in medical applications, especially for bone and tissue regeneration. The microparticles can be provided as powders or suspensions and are made using processes that preserve BMP-2's bioactivity. They can also be associated with biodegradable carriers for sustained or targeted delivery.

Use CasesContent extracted from patent full text and abstract with AI.

  • Treatment and enhancement of bone healing in fractures, such as tibial, spinal, or maxillofacial bones
  • Support for dental repair, including periodontal disease and tooth regeneration
  • Accelerated wound healing in burns, ulcers, and surgical incisions
  • Regeneration of cartilage in joint injuries or degeneration
  • Therapies for osteoporosis and related skeletal conditions
  • Tissue engineering for reconstructive surgery or implants
  • Veterinary applications in domestic animals and thoroughbred horses for orthopedic or trauma care

BenefitsContent extracted from patent full text and abstract with AI.

  • Improved stability and storage of BMP-2 through microparticle formulation, reducing protein degradation
  • Controlled release and targeted delivery to specific injury or defect sites
  • Versatility in formulation: can be lyophilized (freeze-dried) or suspended in liquid for various delivery methods (e.g., injection, topical application, oral, or implant matrix)
  • Retention of BMP-2 bioactivity after processing, ensuring therapeutic efficacy
  • Potential for combination with other growth factors and bioactive agents, enhancing regenerative outcomes
  • Use of biodegradable carriers allows safe, resorbable delivery within the body
  • Customizable microparticle sizes and release profiles for different clinical needs and tissue targets

Technical Classifications (CPCs)

Main Classifications

Health, Food & Consumer Tech

Sub Classifications

Medical & Vet Science

CPC Codes

A61K9/1688A61K9/1694A61K38/1875A61P1/02A61P17/02A61P19/00A61P19/08A61P19/10A61P25/00

Inventors & Applicants

Applicants

Sofia Susan J

Schwartz Daniel

Friess Wolfgang

Univ Erlangen Nurnberg

Wyeth Corp

Patent Abstract

Disclosed are methods of making bioactive BMP-2 microparticles and methods of using the microparticles.

Key Information

Publication No.

US2012004170A1

Family ID

27734467

Publication Date

2012-01-05

Application No.

US201113014365A

Application Date

2011-01-26

Priority Date

2011-01-26

Granted

Yes (4/16)

Possible Cooperation

For further information please contact the transfer office.